EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Vascular differences between IDH‐ wildtype glioblastoma and astrocytoma IDH ‐mutant grade 4 at imaging and transcriptomic levels

María Del Mar Álvarez-Torres, Adolfo López-Cerdán, Zoraida Andreu, Maria de la Iglesia Vayá, Elies Fuster-Garcia, Francisco García-García, Juan M García-Gómez

NMR in Biomedicine · 2023-11 · 36 (11)

DOI: 10.1002/nbm.5004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 21.07.2023. Verfasst von María Del Mar Álvarez-Torres und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Data Science Laboratory, ITACA (Instituto de Información y Tecnología de las Comunicaciones), Universitat Politècnica de València, Valenci…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Astrocytoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agencia de Investigación de España.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Global agreement in central nervous system (CNS) tumor classification is essential for predicting patient prognosis and determining the correct course of treatment, as well as for stratifying patients for clinical trials at international level. The last update by the World Health Organization of CNS tumor classification and grading in 2021 considered, for the first time, IDH ‐wildtype glioblastoma and astrocytoma IDH ‐mutant grade 4 as different tumors. Mutations in the genes isocitrate dehydrogenase ( IDH ) 1 and 2 occur early and, importantly, contribute to gliomagenesis. IDH mutation produces a metabolic reprogramming of tumor cells, thus affecting the processes of hypoxia and vascularity, resulting in a clear advantage for those patients who present with IDH ‐mutated astrocytomas. Despite the clinical relevance of IDH mutation, current protocols do not include full sequencing for every patient. Alternative biomarkers could be useful and complementary to obtain a more reliable classification. In this sense, magnetic resonance imaging (MRI)‐perfusion biomarkers, such as relative cerebral blood volume and flow, could be useful from the moment of presurgery, without incurring additional financial costs or requiring extra effort. The main purpose of this work is to analyze the vascular and hemodynamic differences between IDH ‐wildtype glioblastoma and IDH ‐mutant astrocytoma. To achieve this, we evaluate and validate the association between dynamic susceptibility contrast‐MRI perfusion biomarkers and IDH mutation status. In addition, to gain a deeper understanding of the vascular differences in astrocytomas depending on the IDH mutation, we analyze the transcriptomic bases of the vascular differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsAstrocytomaHumansTranscriptomeMutationIsocitrate DehydrogenaseBiomarkers

Stichwörter der Autor:innen

IDH mutationMRI-DSC biomarkersastrocytomas grade 4gene expressionvascularity

Substanzen

Isocitrate DehydrogenaseBiomarkers

Autor:innen und Institutionen

  • Biomedical Data Science Laboratory, ITACA (Instituto de Información y Tecnología de las Comunicaciones), Universitat Politècnica de València, Valencia, Spain.
  • Unidad Mixta de Imagen Biomédica FISABIO-CIPF (Centro Investigación Príncipe Felipe), Valencia, Spain.
  • Foundation Valencian Institute of Oncology (FIVO), Valencia, Spain.
  • Unidad de Bioinformática y Bioestadística del CIPF, Valencia, Spain.

Förderung

  • Agencia de Investigación de España

Zitieren

APA

Álvarez-Torres, M. D. M., López-Cerdán, A., Andreu, Z., de la Iglesia Vayá, M., Fuster-Garcia, E., García-García, F., & García-Gómez, J. M. (2023). Vascular differences between IDH‐ wildtype glioblastoma and astrocytoma IDH ‐mutant grade 4 at imaging and transcriptomic levels. NMR in Biomedicine, 36(11). https://doi.org/10.1002/nbm.5004

Vancouver

Álvarez-Torres MDM, López-Cerdán A, Andreu Z, de la Iglesia Vayá M, Fuster-Garcia E, García-García F, et al. Vascular differences between IDH‐ wildtype glioblastoma and astrocytoma IDH ‐mutant grade 4 at imaging and transcriptomic levels. NMR in Biomedicine. 2023;36(11). doi:10.1002/nbm.5004

BibTeX
@article{lvarezTorres2023,
  author = {Álvarez-Torres, María Del Mar and López-Cerdán, Adolfo and Andreu, Zoraida and de la Iglesia Vayá, Maria and Fuster-Garcia, Elies and García-García, Francisco and García-Gómez, Juan M},
  title = {Vascular differences between IDH‐ wildtype glioblastoma and astrocytoma IDH ‐mutant grade 4 at imaging and transcriptomic levels},
  journal = {NMR in Biomedicine},
  year = {2023},
  volume = {36},
  number = {11},
  doi = {10.1002/nbm.5004}
}
Kostenlos starten →